Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,863,353 papers from all fields of science
Search
Sign In
Create Free Account
TACSTD2 protein, human
Known as:
Gastrointestinal Tumor-Associated Antigen GA7331
, TROP2 protein, human
, TROP-2
Expand
Tumor-associated calcium signal transducer 2 (323 aa, ~36 kDa) is encoded by the human TACSTD2 gene. This protein is involved in calcium-dependent…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Broader (2)
Antigens, Neoplasm
Cell Adhesion Molecules
Calcium Signaling
EPCAM gene
EPCAM wt Allele
Edrecolomab
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The Diagnostic Validity of TROP-2 in Recognizing Papillary Thyroid Carcinoma
Nehal M. Nabil
,
A. Abdou
,
M. Shaban
,
R. Abdallah
2018
Corpus ID: 209455663
Background: Thyroid cancer is currently the third fastest rising cancer diagnosis in the United States and represents 80.3% of…
Expand
2016
2016
Selective killing of human cancer cells by targeting a fusion mRNA between CYCLIN D1 and TROP2.
S. Alberti
,
M. Trerotola
,
+7 authors
E. Guerra
Journal of Clinical Oncology
2016
Corpus ID: 25931105
e14569 Background: Trop-2 is a calcium signal transducer and a stem cell marker. Trop-2 is widely overexpressed by human cancers…
Expand
2016
2016
Abstract 463: Immunohistochemical study of TROP-2 protein expression in thyroid lesions
Zhiming Liao
2016
Corpus ID: 79142960
Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA Introduction Tumor-associated calcium signal…
Expand
2015
2015
Therapy of advanced metastatic lung cancer with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): Phase I/II clinical experience.
M. Guarino
,
A. Starodub
,
+10 authors
D. Goldenberg
2015
Corpus ID: 79441661
2504 Background: Sacituzumab govitecan (IMMU-132) is a new ADC comprising SN-38, the active metabolite of the topoisomerase…
Expand
2015
2015
Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts
M. Trerotola
,
K. Ganguly
,
+12 authors
L. Languino
OncoTarget
2015
Corpus ID: 52848304
Enhancement Program grant with the Pennsylvania Department of Health (H.R.); the Department specifically disclaims responsibility…
Expand
2013
2013
Abstract C67: Safety, efficacy, and pharmacokinetics of a new humanized anti-Trop-2 antibody-SN-38 conjugate (IMMU-132) for the treatment of diverse epithelial cancers: Phase I clinical experience.
A. Starodub
,
A. Ocean
,
+10 authors
D. Goldenberg
2013
Corpus ID: 84657502
Trop-2 (trophoblastic antigen-2; aka EGP-1, GA733-1) is a surface glycoprotein differentially expressed on a variety of malignant…
Expand
2012
2012
Co-localisation of advanced glycation end products and d-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy
Y. Kaji
,
T. Oshika
,
Y. Takazawa
,
M. Fukayama
,
N. Fujii
British Journal of Ophthalmology
2012
Corpus ID: 11178022
Purpose Gelatinous drop-like corneal dystrophy (GDLD), also known as familial subepithelial corneal amyloidosis, is an autosomal…
Expand
2012
2012
89Zr-Desferrioxamine-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody
K. Leung
2012
Corpus ID: 100568181
2010
2010
Abstract 5346: A novel immunotoxin comprising quadruple RNase tethered to an internalizing anti-TROP-2 humanized MAb shows potent cytotoxicity against diverse solid tumorsin vitro
Thomas M Cardillo
,
E. Rossi
,
R. Arrojo
,
E. Chan
,
D. Goldenberg
,
Chien‐Hsing Chang
2010
Corpus ID: 57809923
Ribonucleases (RNase) are potential anti-tumor agents, and their potency can be enhanced by recombinant fusion or chemical…
Expand
2010
2010
Combination 90Y-hPAM4 radioimmunotherapy (RAIT) and anti-epithelial glycoprotein-1 (EGP-1)-SN-38 antibody-drug conjugate (ADC) improves pancreatic cancer therapy without increasing toxicity
H. Karacay
,
S. Govindan
,
R. Sharkey
,
D. Goldenberg
2010
Corpus ID: 74317827
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE